Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma

被引：9
|
作者：
Jakob, J. A. [1 ]
Bassett, R. L. [1 ]
Ng, C. S. [1 ]
Lazar, A. J. F. [1 ]
Alvarado, G. C. [1 ]
Rohlfs, M. L. [1 ]
Richard, J. [1 ]
Gershenwald, J. E. [1 ]
Hwu, P. [1 ]
Kim, K. B. [1 ]
Davies, M. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8500
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Characteristics and Outcomes With Specific BRAF and NRAS Mutations in Patients With Metastatic Melanoma
    Bucheit, Amanda D.
    Syklawer, Erica
    Jakob, John A.
    Bassett, Roland L., Jr.
    Curry, Jonathan L.
    Gershenwald, Jeffrey E.
    Kim, Kevin B.
    Hwu, Patrick
    Lazar, Alexander J.
    Davies, Michael A.
    CANCER, 2013, 119 (21) : 3821 - 3829
  • [2] Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
    Sakaizawa, Kaori
    Ashida, Atsuko
    Uchiyama, Aya
    Ito, Takamichi
    Fujisawa, Yasuhiro
    Ogata, Dai
    Matsushita, Shigeto
    Fujii, Kazuyasu
    Fukushima, Satoshi
    Shibayama, Yoshitsugu
    Hatta, Naohito
    Takenouchi, Tatsuya
    Uehara, Jiro
    Okuyama, Ryuhei
    Yamazaki, Naoya
    Uhara, Hisashi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 80 (01) : 33 - 37
  • [3] BRAF and NRAS mutations in Metastatic Melanoma Patients with Leptomeningeal Disease
    Patel, Sapna Pradyuman
    Lam, Sruti
    Rohlfs, Michelle L.
    Fox, Patricia S.
    Richard, Jessie
    Iqbal, Masood
    Bernzen, Theresa
    Glitza, Isabella Claudia
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Davies, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Tumor Heterogeneity in Metastatic Melanoma Patients with BRAF/NRAS Mutations
    Yoon, C. H.
    Le, J.
    Ibrahim, N.
    Gold, J.
    Bertagnolli, M. M.
    Hodi, F. S.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S23 - S23
  • [5] Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma
    Syklawer, E. E.
    Jakob, J.
    Bassett, R. L.
    Gershenwald, J. E.
    Prieto, V. G.
    Curry, J. L.
    Davies, M. A.
    Lazar, A. J.
    MODERN PATHOLOGY, 2012, 25 : 135A - 135A
  • [6] Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma
    Syklawer, E. E.
    Jakob, J.
    Bassett, R. L.
    Gershenwald, J. E.
    Prieto, V. G.
    Curry, J. L.
    Davies, M. A.
    Lazar, A. J.
    LABORATORY INVESTIGATION, 2012, 92 : 135A - 135A
  • [7] The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort
    Ekedahl, H.
    Cirenajwis, H.
    Harbst, K.
    Carneiro, A.
    Nielsen, K.
    Olsson, H.
    Lundgren, L.
    Ingvar, C.
    Jonsson, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (05) : 1049 - 1055
  • [8] Clinical significance of BRAF/NRAS concurrent mutations in a clinic-based metastatic melanoma cohort
    del Regno, L.
    Louveau, B.
    Battistella, M.
    Sadoux, A.
    Baroudjian, B.
    Delyon, J.
    Serror, K.
    Allayous, C.
    Lebbe, C.
    Mourah, S.
    Jouenne, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1281 - 1283
  • [9] Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
    Ellerhorst, Julie A.
    Greene, Victoria R.
    Ekmekcioglu, Suhendan
    Warneke, Carla L.
    Johnson, Marcella M.
    Cooke, Carolyn P.
    Wang, Li-E
    Prieto, Victor G.
    Gershenwald, Jeffrey E.
    Wei, Qingyi
    Grimm, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2011, 17 (02) : 229 - 235
  • [10] Clinical significance of BRAF mutations in metastatic melanoma
    Chang D.Z.
    Panageas K.S.
    Osman I.
    Polsky D.
    Busam K.
    Chapman P.B.
    Journal of Translational Medicine, 2 (1)
12345